Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-02-20 @ 6:38 PM
Study NCT ID:
NCT00644657
Status:
COMPLETED
Last Update Posted:
2011-10-07
First Post:
2008-03-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
Sponsor:
University of Oklahoma
Organization:
Study Overview
Official Title:
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagulable.
Detailed Description:
Platelet activity will be determined by light transmission aggregometry at baseline, after a 300 mg dose of clopidogrel and after the catheterization and/or angioplasty procedure. The change in the percentage of platelets that are coated platelets will be determined.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: